GERN vs VRTX: Which Stock is Better?
Side-by-side comparison of Geron Corp and Vertex Pharmaceuticals Inc in 2026
GERN
Geron Corp
$1.66
VRTX
Vertex Pharmaceuticals Inc
$438.71
Key Metrics Comparison
| Metric | GERN | VRTX | Winner |
|---|---|---|---|
| Market Cap | $1.06B | $113.60B | VRTX |
| P/E Ratio | N/A | 29.16 | VRTX |
| EPS (TTM) | $N/A | $15.34 | VRTX |
| Revenue Growth | 0.0% | 0.1% | VRTX |
| Gross Margin | 97.4% | 53.7% | GERN |
Analyze GERN
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GERN or VRTX a better investment?
Comparing GERN and VRTX: Geron Corp has a market cap of $1.06B while Vertex Pharmaceuticals Inc has $113.60B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GERN and VRTX?
GERN (Geron Corp) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GERN or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: GERN or VRTX?
VRTX has higher revenue growth at 0.1% vs 0.0% for GERN.
Which company is more profitable: GERN or VRTX?
Geron Corp (GERN) has higher gross margins at 97.4% compared to 53.7% for VRTX.
Which is the larger company: GERN or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $113.60B compared to $1.06B for GERN.
Should I buy GERN or VRTX in 2026?
Both GERN and VRTX have investment merit. GERN trades at $1.66 while VRTX trades at $438.71. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GERN and VRTX stock?
Key differences: Market Cap ($1.06B vs $113.60B), P/E Ratio (N/A vs 29.2x), Revenue Growth (0.0% vs 0.1%), Gross Margin (97.4% vs 53.7%).